Cprx stock forecast.
The current Catalyst Pharmaceuticals [ CPRX] share price is $13.16. The Score for CPRX is 64, which is 28% above its historic median score of 50, and infers lower risk than normal. CPRX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Dec 1, 2023 · Catalyst Pharmaceuticals last released its quarterly earnings data on November 8th, 2023. The biopharmaceutical company reported ($0.26) earnings per share for the quarter, hitting the consensus estimate of ($0.26). The business earned $102.69 million during the quarter, compared to the consensus estimate of $100.17 million. Track Catalyst Pharmaceuticals Inc (CPRX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsHeading out for an outdoor adventure? Whether you’re planning a picnic, a hiking trip, or a beach day, one essential tool you need in your arsenal is a detailed weather 10 day forecast.Find the latest Catalyst Pharmaceuticals, Inc. (CPRX) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo FinanceAug 16, 2023 · Find the latest Catalyst Pharmaceuticals, Inc. (CPRX) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance
The U.S. National Weather Service (NWS) is a part of the National Oceanic and Atmospheric Administration (NOAA). Many people rely on the National Weather Service’s forecasts in order to better anticipate what the weather will be like so the...Mar 10, 2023 · For the current quarter, Catalyst is expected to post earnings of $0.21 per share, indicating a change of +133.3% from the year-ago quarter. The Zacks Consensus Estimate remained unchanged over ... Nov 24, 2023 · Based on short-term price targets offered by five analysts, the average price target for Catalyst Pharmaceutical comes to $23.30. The forecasts range from a low of $15.50 to a high of $27.00. The ...
Check price target & stock forecast for Catalyst here>>> While the ABR calls for buying Catalyst, it may not be wise to make an investment decision solely based on this information.8 brokers have issued 1-year price objectives for RealReal's stock. Their REAL share price targets range from $1.85 to $6.00. On average, they predict the company's stock price to reach $3.45 in the next twelve months. This suggests a possible upside of 55.4% from the stock's current price. View analysts price targets for REAL or view top-rated ...
Fiscal Q3 2023 ended 9/30/23. Reported on 11/8/23. Get the latest Catalyst Pharmaceuticals Inc (CPRX) real-time quote, historical performance, charts, and other financial …Dec 1, 2023 · Catalyst Pharmaceuticals last released its quarterly earnings data on November 8th, 2023. The biopharmaceutical company reported ($0.26) earnings per share for the quarter, hitting the consensus estimate of ($0.26). The business earned $102.69 million during the quarter, compared to the consensus estimate of $100.17 million. CPRX - Free Report) is scheduled to report its first-quarter 2023 results on May 10, 2023. Catalyst Pharmaceuticals’ earnings surprise history has been mixed so far. The company’s earnings ...According to the issued ratings of 5 analysts in the last year, the consensus rating for Altimmune stock is Moderate Buy based on the current 1 hold rating and 4 buy ratings for ALT. The average twelve-month price prediction for Altimmune is $13.80 with a high price target of $25.00 and a low price target of $6.00.Check price target & stock forecast for Catalyst here>>> While the ABR calls for buying Catalyst, it may not be wise to make an investment decision solely based on this information.
Long term stock idea: CPRX (Small Cap Biotech) When markets are messy I like to explore long term bases in relatively unknown stocks. CPRX has a 15 year base with contracting volatility in recent years, mostly since 2019. I like the look of the quarterly chart and I like the volume markers on the daily - institutional funds have been progress When markets are …
2021. Revenue. $302.9M. Sources. Catalyst Pharmaceuticals (CPRX) Stock Price Performance. Catalyst Pharmaceuticals (CPRX) Stock Key Data. Summary Additional Data Analysts Historical Quotes.
7 brokerages have issued 12-month price targets for Cross Country Healthcare's shares. Their CCRN share price targets range from $21.00 to $40.00. On average, they anticipate the company's share price to reach $27.50 in the next year. This suggests a possible upside of 34.7% from the stock's current price.Catalyst Pharmaceuticals had non-GAAP profits of 41 cents, a full dime a share over the consensus. On a GAAP basis, earnings were 26 cents a share for the quarter, an improvement of 117% from ...Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Lightning eMotors Inc have a median target of 7.00, with a high estimate of 7.00 and a low estimate of 7.00. The median ... WeCommerce Holdings Ltd. Class A (WE) Stock Forecast & Price TargetAccording to 4 stock analysts, the average 12-month stock price forecast for CPRX stock stock is $23.75, which predicts an increase of 64.59%. The lowest target is $20 and the highest is $27. On average, analysts rate CPRX stock stock as a strong buy. Analyst Consensus: Strong Buy * Price targets were last updated on Aug 22, 2023. Analyst RatingsCatalyst Pharmaceutical (CPRX) closed at $16.60 in the latest trading session, marking a -0.12% move from the prior day. This move was narrower than the S&P 500's daily loss of 0.7%.
Year-to-date, Catalyst Pharmaceuticals (NASDAQ:CPRX) stock price is down 25%, despite the company’s strong 1Q 2023 results (however, not as strong as in 4Q 2022), and despite a promising full ...SWN Stock 12 Months Forecast. $8.53. (27.98% Upside) Based on 13 Wall Street analysts offering 12 month price targets for Southwestern Energy in the last 3 months. The average price target is $8.53 with a high forecast of $15.00 and a low forecast of $5.50. The average price target represents a 27.98% change from the last price of $6.67.VOD Stock 12 Months Forecast. $14.45. (52.11% Upside) Based on 1 Wall Street analysts offering 12 month price targets for Vodafone in the last 3 months. The average price target is $14.45 with a high forecast of $14.45 and a low forecast of $14.45. The average price target represents a 52.11% change from the last price of $9.50.May 11, 2023 · Analyst forecasts along with ownership data serve to give a strong idea about prospects for a business Every investor in Catalyst Pharmaceuticals, Inc. ( NASDAQ:CPRX ) should be aware of the most ... Dec 1, 2023 · CPRX Signals & Forecast The Catalyst Pharmaceuticals stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. Mar 10, 2023 · For the current quarter, Catalyst is expected to post earnings of $0.21 per share, indicating a change of +133.3% from the year-ago quarter. The Zacks Consensus Estimate remained unchanged over ...
Catalyst Pharmaceuticals Stock Chart and Share Price Forecast, Short-Term "CPRX" Stock Prediction for Next Days and Weeks Walletinvestor.com Catalyst Pharmaceuticals Inc (CPRX) Forecast Chart, Long-Term Predictions for Next Months and Year: 2023, 2024 About the Catalyst Pharmaceuticals, Inc. stock forecast. As of 2023 November 26, Sunday current price of CPRX stock is 14.060$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).
The stock, however, lost 2.1% during the after-market hours on Thursday. CPRX reported earnings of 33 cents per share for the second quarter of 2023, beating the Zacks Consensus Estimate of 25 cents.TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.com14 Days Historical Data CPRX : Catalyst Pharmaceuticals stock forecast by Wall Street Analysts The average Catalyst Pharmaceuticals stock forecast from last 6 month is …For Catalyst Pharmaceuticals Stock (CPRX) price forecast for 2024, the average price target for Catalyst Pharmaceuticals Stock is $17.29 with a high forecast of $22.19 and a low forecast of $12.39. The average CPRX price prediction of 2024 represents a +31.36% increase from the last price of $13.16. CryptoCurrency Markets, Short-term and Long-term Price Predictions with Forecast Charts, CryptoCurrency Calculators and much more with Smart Technical AnalysisView the latest Catalyst Pharmaceuticals Inc. (CPRX) stock price, news, historical charts, analyst ratings and financial information from WSJ.Q4 2023 EPS Estimate Trends. Current. $0.32. 1 Month Ago. $0.33. 3 Months Ago. $0.32. Catalyst Pharmaceuticals Inc. analyst estimates, including CPRX earnings per share estimates and analyst ...Throughout the U.S., the weather can be quite unpredictable, even with state-of-the-art radar, sensors and computer modeling technology right at meteorologists’ fingertips. The Old Farmer’s Almanac first provided valuable statistics and dat...Jan 8, 2023 · Shares of CPRX were one of the market’s most successful stock stories in 2022. That’s because they delivered investors a year-to-date gain of over 136% (through Dec. 16). And while it’s true ...
The current average CPRX price target, as estimated by these analysts, is $19.38. The predictions for the future CPRX stock price range from a low of $15.50 to a high of …
Stock Price Forecast The 9 analysts offering 12-month price forecasts for Blink Charging Co have a median target of 5.00, with a high estimate of 25.00 and a low estimate of 3.00.
Stock Price Forecast. The 10 analysts offering 12-month price forecasts for Capri Holdings Ltd have a median target of 57.00, with a high estimate of 57.00 and a low estimate of 55.00. The median ... 6 mar 2023 ... Catalyst Pharmaceuticals Inc. Common Stock, CPRX stock forecast, stock analysis, stock rating, stock news, share price, company information, ...The average Biogen stock price prediction forecasts a potential upside of 40.68% from the current BIIB share price of $231.25. What is BIIB's forecast return on equity (ROE) for 2023-2026? (NASDAQ: BIIB) forecast ROE is N/A, which is considered weak.Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Inpixon have a median target of 586,488.00, with a high estimate of 586,488.00 and a low estimate of 586,488.00. The ...Mar 22, 2023 · Shares of Catalyst Pharmaceutical (CPRX) have gained 8.4% over the past four weeks to close the last trading session at $16.53, but there could still be a solid upside left in the stock if short ... Stock Price Forecast The 5 analysts offering 12-month price forecasts for Catalyst Pharmaceuticals Inc have a median target of 24.00, with a high estimate of 27.00 and a low estimate of...1. Catalyst Pharmaceuticals. Catalyst Pharmaceuticals ( CPRX 1.44%) is crushing Tesla stock because it's in the process of cornering a rare disease market that'll be worth hundreds of millions of ...Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...
Catalyst Pharmaceutical (CPRX) closed at $16.60 in the latest trading session, marking a -0.12% move from the prior day. This move was narrower than the S&P 500's daily loss of 0.7%.Catalyst (CPRX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.CPRX Stock Forecast: Bull Case. Targeting Rare Disease LEMS – Lambert Eaton myasthenic syndrome (LEMS) is a condition of immune system attacking neuromuscular junctions- where nerves and muscles meet and is associated with small cell lung cancer. It hit the market in 2019.Fiscal Q3 2023 ended 9/30/23. Reported on 11/8/23. Get the latest Catalyst Pharmaceuticals Inc (CPRX) real-time quote, historical performance, charts, and other financial …Instagram:https://instagram. trade the pool reviewbest broker for forex ustrta dental and vision insurancenon qm mortgage lenders near me Change. % Change. CPRX. Catalyst Pharmaceuticals, Inc. 12.71. -0.31. -2.38%. According to the average brokerage recommendation (ABR), one should invest in Catalyst (CPRX). It is debatable whether ... flow beverageutah medical products Based on short-term price targets offered by five analysts, the average price target for Catalyst Pharmaceutical comes to $23.30. The forecasts range from a low of $15.50 to a high of $27.00. The ... upcoming mergers Find the latest Prime Medicine, Inc. (PRME) stock quote, history, news and other vital information to help you with your stock trading and investing.CPRX Stock Price Forecast. We consider Catalyst Pharmaceuticals Inc. Common Stock Decision Process with Deductive Inference (ML) where A is the set of discrete actions of CPRX stock holders, F is the set of discrete states, P : S × F × S → R is the transition probability distribution, R : S × F → R is the reaction function, and γ ∈ [0, 1] is a move factor for expectation. 1,2,3,4What this means: InvestorsObserver gives Catalyst Pharm Inc (CPRX) an overall rank of 36, which is below average. Catalyst Pharm Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 36 means that 64% of stocks appear more favorable to our system.